|
시장보고서
상품코드
2077946
섬유소용해요법 시장 : 약제 종류별, 적응증별, 최종사용자별, 투여 방법별, 유통 채널별, 환자 연령별, 포장 형태별, 용도별, 제형별, 지역별Fibrinolytic Therapy Market By Drug Type, By Indication, By End User, By Administration (Intravenous, Intra-arterial ), By Distribution Channel, By Patient Age, By Packaging Type, By Application, By Dosage Form, By Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
섬유소용해요법 시장은 2026년에 390억 6,000만 달러 규모에 달할 것으로 추정되며, 2033년까지 510억 5,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 3.9%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 390억 6,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 3.90% | 예측 금액(2033년) | 510억 5,000만 달러 |
섬유소용해요법은 심근경색이나 뇌졸중을 유발하는 혈전을 용해하기 위해 사용됩니다. 이 치료법은 생명을 구할 수는 있지만, 다른 중증 질환이나 병태로 이어질 가능성이 있는 근본적인 건강 문제에 대해서는 효과가 없습니다. 섬유소용해요법은 일반적으로 정맥내 투여를 통해 시행됩니다. 뇌졸중이나 심근경색의 증상이 나타나고, 항응고제나 스테로이드제 등 다른 치료법에 반응이 없는 경우에 사용됩니다. 집에서든 병원에서든 투여가 가능합니다. 조직 플라스미노겐 활성화 인자(t-PA) 또는 알테플라제는 체내에서 혈전을 형성하는 피브린 및 기타 물질을 분해하는 약제로, 섬유소용해요법에서 가장 일반적으로 사용됩니다. 테네크테플라제라는 약제도 일부 환자에게 효과가 있으며, 경구 투여도 가능합니다.
시장 역학:
외상 및 교통사고 발생 건수의 증가가 항섬유소용해제 수요를 견인하고 있으며, 이는 결과적으로 섬유소용해요법 시장의 성장을 뒷받침하고 있습니다. 주로 월경과다(과다월경)에 대한 경구용 출혈 치료에서 이러한 약물의 사용이 증가하고 있는 점도 시장의 추가적인 성장을 촉진할 것으로 예상됩니다. 또한, 심각한 교통사고 및 외상 발생 건수가 증가하고 있는 것이 항섬유소용해제 수요를 창출하고 있으며, 이에 따라 시장 성장을 뒷받침하고 있습니다. 또한, 혈우병, 혈소판 기능 장애, 폰빌레브란트병, A형 및 B형 혈우병 등의 질환 치료에 이러한 약물의 사용이 확대되면서 시장 성장을 더욱 뒷받침하고 있습니다.
또한, 전 세계 섬유소용해요법 시장은 혈전을 유발하는 심혈관질환, 신경계 질환, 폐 질환의 유병률 증가에 힘입어 성장하고 있습니다. 세계보건기구(WHO)에 따르면, 심혈관질환으로 인한 사망자 수는 연간 1,790만 명을 넘습니다. 또한, 이러한 질환에 걸리기 쉬운 고령 인구의 증가도 시장 성장에 기여하고 있습니다. 그러나 섬유소 용해제의 높은 비용, 엄격한 규제, 그리고 치료에 따른 출혈 위험이 시장 확대를 저해하고 있습니다. 이 시장에서는 더 높은 특이성, 피브린에 대한 특이성 향상, 그리고 출혈 위험 감소를 갖춘 효과적인 재조합 변이체, 합성 유사체 및 하이브리드 분자를 개발할 기회가 제공되고 있습니다.
그러나 이러한 약제의 높은 가격은 시장 성장을 저해할 수 있는 중요한 요인이 되고 있습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 섬유소용해요법 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 섬유소용해요법 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 섬유소용해요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 섬유소용해요법 시장
제5장 세계의 섬유소용해요법 시장 : 약제 종류별(2021-2033년)
제6장 세계의 섬유소용해요법 시장 : 적응증별(2021-2033년)
제7장 세계의 섬유소용해요법 시장 : 최종사용자별(2021-2033년)
제8장 세계의 섬유소용해요법 시장 : 투여 방법별(2021-2033년)
제9장 세계의 섬유소용해요법 시장 : 유통 채널별(2021-2033년)
제10장 세계의 섬유소용해요법 시장 : 환자 연령별(2021-2033년)
제11장 세계의 섬유소용해요법 시장 : 포장 형태별(2021-2033년)
제12장 세계의 섬유소용해요법 시장 : 용도별(2021-2033년)
제13장 세계의 섬유소용해요법 시장 : 제형별(2021-2033년)
제14장 세계의 섬유소용해요법 시장 : 지역별(2021-2033년)
제15장 경쟁 구도
제16장 섹션
KSM 26.07.13Fibrinolytic Therapy Market is estimated to be valued at USD 39.06 Bn in 2026 and is expected to reach USD 51.05 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 39.06 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.90% | 2033 Value Projection: | USD 51.05 Bn |
Fibrinolytic therapy is used to dissolve blood clots that cause heart attacks or strokes. It is a lifesaving treatment, but it fails in underlying health problems that can lead to other serious diseases and conditions. Thrombolysis is usually given through an intravenous line. It is used when symptoms of a stroke or heart attack are present and the patient is not responding to other treatments, like anticoagulants and steroid medications. It can be given at home or in a hospital. Tissue plasminogen activator or alteplase is a drug that breaks down fibrin and other substances that create clots in the body that is most commonly used for thrombolysis. The drug tenecteplase is also effective in some patients, and it can also be given by mouth.
Market Dynamic:
The increasing incidences of trauma and road accidents are driving the demand for antifibrinolytic drugs, which in turn is fuelling fibrinolytic therapy market growth. The growing use of these drugs in oral bleeding treatments, mainly for menorrhagia (heavy menstrual flow) is again anticipated to bolster the market growth further. Moreover, rising incidences of severe road accidents and trauma is creating demand for anti-fibrinolytic drugs, thereby propelling the market growth. Furthermore, rising adoption of these drugs for treating hemophilia and other conditions such as platelet dysfunctions, Von Willebrand diseases and haemophilia A and B is further bolstering the market growth.
Also, the global fibrinolytic therapy market is driven by the rising prevalence of cardiovascular diseases, neurological disorders and pulmonary diseases causing blood clots. As per World Health Organization (WHO), cardiovascular diseases accounts for over 17.9 Mn deaths annually. Moreover, growing geriatric population prone to such diseases contributes to the market growth. However, high costs of fibrinolytic drugs, stringent regulations, and risk of bleeding associated with the therapy inhibits the market expansion. The market provides opportunities for development of effective recombinant variants, synthetic analogs, and hybrid molecules with greater specificity, enhanced fibrin specificity and reduced bleeding risks.
However, the high price of these drugs is a key factor that can hinder the market growth.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global fibrinolytic therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Genentech, Inc. (Roche), Bayer AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Bristol Myers Squibb Company, Novartis AG, AstraZeneca PLC, Johnson & Johnson, Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Mallinckrodt Pharmaceuticals, and Mitsubishi Tanabe Pharma Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global fibrinolytic therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibrinolytic therapy market
Detailed Segmentation:
- Global Fibrinolytic Therapy Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Alteplase
- Reteplase
- Tenecteplase
- Streptokinase
- Anistreplase
- Urokinase
- Global Fibrinolytic Therapy Market, By Indication:
- Acute Ischemic Stroke
- Acute Myocardial Infarction
- Deep Vein Thrombosis
- Peripheral Arterial Thrombosis
- Other Arterial Thrombosis
- Global Fibrinolytic Therapy Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
- Global Fibrinolytic Therapy Market, By Administration:
- Intravenous (IV)
- Intra-arterial (IA)
- Global Fibrinolytic Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Fibrinolytic Therapy Market, By Patient Age:
- Adult Patients
- Pediatric Patients
- Global Fibrinolytic Therapy Market, By Packaging Type:
- Vials
- Ampoules
- Pre-filled Syringes
- Global Fibrinolytic Therapy Market, By Application:
- Emergency Care
- Interventional Cardiology
- Thrombosis Treatment
- Others
- Global Fibrinolytic Therapy Market, By Dosage Form:
- Lyophilized Powder for Reconstitution
- Solution for Injection
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Fibrinolytic Market:
- Genentech, Inc. (Roche)
- Bayer AG
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- Bristol Myers Squibb Company
- Novartis AG
- AstraZeneca PLC
- Johnson & Johnson
- Daiichi Sankyo Company, Limited
- Merck & Co., Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Abbott Laboratories
- Mallinckrodt Pharmaceuticals
- Mitsubishi Tanabe Pharma Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Patient Age
- Market Snippet, By Packaging Type
- Market Snippet, By Application
- Market Snippet, By Dosage Form
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Increasing incidence of cardiovascular diseases
- Growing geriatric population
- Technological advancements
- Access to healthcare facilities
- Restrain
- Limited efficacy in certain patient populations
- Risk of bleeding complications
- Availability of alternative treatment modalities
- Time sensitivity and door-to-needle delays
- Opportunities
- Emerging markets
- Combination therapies
- Telemedicine and remote treatment
- Personalized medicine
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Mergers, Acquisitions, and Collaborations
- Driver
4. Global
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Fibrinolytic Therapy Market, By Drug Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Alteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Reteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Tenacteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Streptokinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Anistreplase
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Urokinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Fibrinolytic Therapy Market, By Indication, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Acute Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Acute Myocardial Infarction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Deep Vein Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Peripheral Arterial Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Other Arterial Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,US$ Bn(US$ Bn)
7. Global Fibrinolytic Therapy Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Speciality Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Fibrinolytic Therapy Market, By Administration, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Intra-arterial (IA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
9. Global Fibrinolytic Therapy Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
10. Global Fibrinolytic Therapy Market, By Patient Age, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
11. Global Fibrinolytic Therapy Market, By Packaging Types, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
12. Global Fibrinolytic Therapy Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Emergency Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Interventional Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Thrombosis Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
13. Global Fibrinolytic Therapy Market, By Dosage Form, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Lyophilized Powder for Reconstitution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Solution for Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
14. Global Fibrinolytic Therapy Market , By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 €"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- South Africa
- Central Africa
- North Africa
15. Competitive Landscape
- Company Profile
- Genentech, Inc. (Roche)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bristol Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novarts AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Daiichi Sankyo Company, Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mitsubishi Tanabe Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genentech, Inc. (Roche)
- Analyst Views
16. Section
- References
- Research Methodology
- About us
